EFFICACY AND SAFETY OF PRE-PROCEDURAL PRASUGREL IN ASIANS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROME: A REPORT FROM A JAPANESE MULTICENTER REGISTRY

The aim of this study was to compare the risk for ischemic and bleeding events associated with prasugrel versus clopidogrel in Asians undergoing percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS) using propensity score matching analysis. Major ischemic events were defined as...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2018-03, Vol.71 (11), p.A170-A170
Main Authors: Shoji, Satoshi, Sawano, Mitsuaki, Shiraishi, Yasuyuki, Ikemura, Nobuhiro, Ueda, Ikuko, Numasawa, Yohei, Noma, Shigetaka, Suzuki, Masahiro, Hayashida, Kentaro, Yuasa, Shinsuke, Fukuda, Keiichi, Kohsaka, Shun
Format: Article
Language:English
Subjects:
Acute coronary syndromes
Angioplasty
Cardiology
Heart attacks
Hemorrhage
Patients
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The aim of this study was to compare the risk for ischemic and bleeding events associated with prasugrel versus clopidogrel in Asians undergoing percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS) using propensity score matching analysis. Major ischemic events were defined as the composite of in-hospital death, recurrent myocardial infarction and ischemic stroke.
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(18)30711-3